
This program was supported by an educational grant from Amgen Canada.
Program Material
PLANNING COMMITTEE DISCLOSURES
Planning Committee Member | Disclosures | |
---|---|---|
![]() | Jonathan Adachi, MD, FRCPC Professor Department of Medicine McMaster University | Speaker’s Bureau/Honoraria: Amgen, Gilead, GlaxoSmithKline, and CPD Network |
![]() | Jeff Habert, MD, CCFP, FCFP Assistant Professor Department of Family and Community Medicine University of Toronto |
Speaker’s Bureau/Advisory Board: Boehringer, Eli Lilly, Elvium, Takeda, Bausch, Astra Zeneca, Novartis, Lundbeck, Novo Nordisk, Janssen, Eisai, HLS, Otsuka, Idorsia, Pfizer, Amgen, Abbvie, GSK, Bayer, and Valeo |
![]() | David Kendler, MD, FRCPC, CCD Clinical Professor Department of Medicine |
Speaker’s Bureau/Honoraria: Amgen, CPD Network |
![]() | Anne Morisset, MD, FRCPC Clinical Professor Department of Medicine Sherbrooke University | Speaker’s Bureau/Honoraria: Amgen, Mantra Pharma, Paladin, Novo Nordisk, Sanofi, Eli Lilly, and CPD Network |
![]() | Christine Palmay, MD, CCFP Family Physician Midtown Health and Wellness Clinic Toronto, ON | Speaker’s Bureau/Honoraria: Pfizer, Merck, Allergan, Bayer, GSK, Galderma, Valeant, Lundbeck, AZ, Bausch Health, Sunovion, Nuvopharm, Novartis, Searchlight, Knight, AbbVie, Sanofi, Sequiris, Sunpharma, and Idorsia |